Cordova Ashley Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$4.3M

Insider Activity of Cordova Ashley

Biography of Cordova Ashley

No biography is available at this moment.

2025-09-05PurchaseNovoCure Limited
NVCR
Chief Executive Officer
81,550
0.0726%
$12.22$996,859+9.77%
2025-03-03SaleNovoCure Limited
NVCR
Chief Executive Officer
2,053
0.0019%
$18.54$38,055-25.8%
2025-02-28SaleNovoCure Limited
NVCR
Chief Executive Officer
2,341
0.0021%
$18.28$42,804-28.11%
2025-02-27SaleNovoCure Limited
NVCR
Chief Executive Officer
11,153
0.0106%
$20.02$223,323-28.5%
2024-08-02SaleNovoCure Limited
NVCR
Chief Financial Officer
688
0.0006%
$20.14$13,857-13.28%
2023-09-01SaleNovoCure Limited
NVCR
Chief Financial Officer
883
0.0008%
$21.82$19,265-31.34%
2023-08-02SaleNovoCure Limited
NVCR
Chief Financial Officer
1,144
0.0011%
$30.25$34,607-49.12%
2023-03-03SaleNovoCure Limited
NVCR
Chief Financial Officer
5,505
0.0051%
$76.16$419,258-73.06%
2023-03-03SaleNovoCure Limited
NVCR
Chief Financial Officer
4,730
0.0044%
$76.16$360,234-73.06%
2023-03-02SaleNovoCure Limited
NVCR
Chief Financial Officer
1,055
0.001%
$75.28$79,418-71.48%
2023-03-01SaleNovoCure Limited
NVCR
Chief Financial Officer
2,198
0.0021%
$76.36$167,845-71.58%
2022-09-02SaleNovoCure Limited
NVCR
Chief Financial Officer
885
0.0008%
$79.04$69,948-9.11%
2022-03-08SaleNovoCure Limited
NVCR
Chief Financial Officer
759
0.0007%
$70.10$53,206+11.28%
2022-03-03SaleNovoCure Limited
NVCR
Chief Financial Officer
556
0.0005%
$70.41$39,146+4.71%
2021-11-02SaleNovoCure Limited
NVCR
Chief Financial Officer
209
0.0002%
$107.28$22,421-27.59%
2021-09-02SaleNovoCure Limited
NVCR
Chief Financial Officer
828
0.0008%
$138.23$114,456-42.95%
2021-08-12SaleNovoCure Limited
NVCR
Chief Financial Officer
16,559
0.0158%
$140.96$2.33M-43.37%
2021-03-08SaleNovoCure Limited
NVCR
Chief Financial Officer
765
0.0008%
$130.81$100,067+1.98%
2021-03-04SaleNovoCure Limited
NVCR
Chief Financial Officer
567
0.0006%
$137.55$77,993-2.79%
2021-03-02SaleNovoCure Limited
NVCR
Chief Financial Officer
428
0.0004%
$152.05$65,079-14.45%
Total: 21
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.